Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis

Rama Subba Rao Vidadala, Kasey L. Rivas, Kayode K. Ojo, Matthew A. Hulverson, Jennifer A. Zambriski, Igor Bruzual, Tracey L. Schultz, Wenlin Huang, Zhongsheng Zhang, Suzanne Scheele, Amy E. DeRocher, Ryan Choi, Lynn K. Barrett, Latha Kallur Siddaramaiah, Wim G.J. Hol, Erkang Fan, Ethan A. Merritt, Marilyn Parsons, Gail Freiberg, Kennan MarshDale J. Kempf, Vern B. Carruthers, Nina Isoherranen, J. Stone Doggett, Wesley C. Van Voorhis, Dustin J. Maly

Research output: Contribution to journal › Article › peer-review

77 Scopus citations

Fingerprint

Dive into the research topics of 'Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds